The study regarding screening tests for HIV complications associated with aging in HIV infected patients.

The study regarding screening tests for HIV complications associated with aging in HIV infected patients. - The study of HIV complications and PET

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024741

Enrollment

Registered

2016-11-10

Start date

2016-11-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection

Interventions

Starting November 2016 to end of March 2019, we will conduct two malignant tumor screening tests, including FDG-PET/ CT examination, chest CT examination, upper gastrointestinal endoscopy, blood tumor

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) HIV infected patients with hemophilia who are 35 years old or older 2) A consent to participate has been obtained in a written form.

Exclusion criteria

Exclusion criteria: 1) If an attending physician decides the patient requires urgent treatment 2) A patient with poor control of diabetes (FBS>150mg/dL) 3) A patient with serious underlying disease, which may lead to liver/kidney dysfunction and/or metabolic disorder 4) A patient with mental illness or psychiatric symptoms determined to confront difficulty when participating in the study 5) A patient with history of hypersensitivity to FDG 6) Other patients, whose attending physician has determined inappropriate to participate

Design outcomes

Primary

Measure	Time frame
Presence of undiagnosed malignant tumor and/or dementia in HIV positive patients with hemophilia.	—

Countries

Japan

Contacts

Public ContactShinichi Oka

National Center for Global Health and Medicine AIDS Clinical Center

oka@acc.ncgm.go.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026